Hereditary Transthyretin Amyloidosis (hATTR) Test
A targeted analysis of the TTR gene for diagnosing hereditary transthyretin amyloidosis, powered by the Helix Exome+® platform for precise variant detection.
6-21 days
≤ 5 days
Test Description
Hereditary transthyretin amyloidosis (hATTR) is a slowly progressive, adult-onset neuromuscular condition, characterized by a gradual buildup of amyloid in different organs, tissues, and nerves.
This test evaluates for hereditary transthyretin amyloidosis through analysis of the TTR gene.
Have Questions?
Our team is available Monday through Friday, 9am-5pm Pacific Time.
Indications for Testing
Providing a genetic evaluation for individuals with a personal and/or family history suggestive of hereditary transthyretin amyloidosis. Establishing a diagnosis of hereditary transthyretin amyloidosis.
Methodology
This test utilizes next-generation sequencing to detect single nucleotide variants, insertions and deletions up to 20 bp, and copy number variants in the TTR gene, which is associated with hereditary transthyretin amyloidosis.
Technical Specifications
Genes Tested
Showing 1 of 1 genes in this panel